| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.16 | 0.001 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.49 | 0.001 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.13 | 0.003 |